etomoxir has been researched along with deoxyglucose in 4 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (deoxyglucose) | Trials (deoxyglucose) | Recent Studies (post-2010) (deoxyglucose) |
---|---|---|---|---|---|
260 | 8 | 93 | 11,426 | 171 | 1,375 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdel-aleem, S; Anstadt, MP; Li, X; Lowe, JE; Perez-Tamayo, RA | 1 |
Bouch, C; Davidson, MB; Lim, J; Marciano, D; Venkatesan, N | 1 |
Ates, YO; Hernlund, E; Ihrlund, LS; Khan, O; Linder, S; Panaretakis, T; Shoshan, MC | 1 |
Aller, P; Boyano-Adánez, Mdel C; Calviño, E; Calvo, S; de Blas, E; Estañ, MC; Guillén-Guío, B; Rial, E | 1 |
4 other study(ies) available for etomoxir and deoxyglucose
Article | Year |
---|---|
Regulation of glucose utilization during the inhibition of fatty acid oxidation in rat myocytes.
Topics: Animals; Crotonates; Deoxyglucose; Epoxy Compounds; Fatty Acids; Glucose; Heart; Hypoglycemic Agents; In Vitro Techniques; Male; Muscle Proteins; Myocardium; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 1994 |
Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation.
Topics: Animals; Biological Transport; Carnitine O-Palmitoyltransferase; Deoxyglucose; Dexamethasone; Epoxy Compounds; Fatty Acids, Nonesterified; Glucocorticoids; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 1996 |
Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Proliferation; Cisplatin; Colonic Neoplasms; Deoxyglucose; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Epoxy Compounds; HCT116 Cells; Humans; Oxidation-Reduction; Reactive Oxygen Species; Time Factors | 2008 |
Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Deoxyglucose; Epoxy Compounds; Glycolysis; Humans; Indazoles; Leukemia, Myeloid, Acute; Oxidative Stress; Oxides; Protein Kinases | 2014 |